VITAMIN-C PREFERENTIAL TOXICITY FOR MALIGNANT-MELANOMA CELLS

[1] Barron ESG, 1936, J BIOL CHEM, V112, P625

[2] SYNERGISTIC KILLING OF EHRLICH ASCITES CARCINOMA CELLS BY ASCORBATE AND 3-AMINO-1,2,4-TRIAZOLE [J]. ONCOLOGY, 1969, 23 (01) : 33 - &

[3] CAMERON E, 1979, CANCER RES, V39, P663

[4] CHATTERJEE GC, 1969, VITAMINS, P399

[5] COOPER M, 1973, YALE J BIOL MED, V46, P705

[6] FAILURE OF HIGH-DOSE VITAMIN-C (ASCORBIC-ACID) THERAPY TO BENEFIT PATIENTS WITH ADVANCED CANCER - CONTROLLED TRIAL [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (13) : 687 - 690

[7] DEUCHER W. G., 1940, Strahlentherapie, V67, P143

[8] DODIN A, 1964, CR HEBD ACAD SCI, V258, P2707

[9] DYER HM, 1950, J NATL CANCER I, V11, P313

[10] HORCICKO J, 1977, SB LEK, V79, P340

[1] Barron ESG, 1936, J BIOL CHEM, V112, P625

[2] SYNERGISTIC KILLING OF EHRLICH ASCITES CARCINOMA CELLS BY ASCORBATE AND 3-AMINO-1,2,4-TRIAZOLE [J]. ONCOLOGY, 1969, 23 (01) : 33 - &

[3] CAMERON E, 1979, CANCER RES, V39, P663

[4] CHATTERJEE GC, 1969, VITAMINS, P399

[5] COOPER M, 1973, YALE J BIOL MED, V46, P705

[6] FAILURE OF HIGH-DOSE VITAMIN-C (ASCORBIC-ACID) THERAPY TO BENEFIT PATIENTS WITH ADVANCED CANCER - CONTROLLED TRIAL [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (13) : 687 - 690

[7] DEUCHER W. G., 1940, Strahlentherapie, V67, P143

[8] DODIN A, 1964, CR HEBD ACAD SCI, V258, P2707

[9] DYER HM, 1950, J NATL CANCER I, V11, P313

[10] HORCICKO J, 1977, SB LEK, V79, P340